Schubert & CO Zoetis Inc. Transaction History

Schubert & CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	BUY	$145.48 - $175.02 $4,073 - $4,900	28 Added 96.55%	57 $9,000
Q4 2022 Jan 31, 2023	SELL	$131.14 - $157.47 $2,885 - $3,464	-22 Reduced 43.14%	29 $4,000
Q3 2022 Oct 21, 2022	SELL	$148.29 - $182.55 $2,224 - $2,738	-15 Reduced 22.73%	51 $8,000
Q2 2022 Aug 01, 2022	BUY	$155.97 - $200.09 $4,835 - $6,202	31 Added 88.57%	66 $11,000
Q1 2022 May 16, 2022	BUY	$181.39 - $234.03 $906 - $1,170	5 Added 16.67%	35 $7,000
Q4 2021 Jan 28, 2022	BUY	$193.69 - $247.03 $5,810 - $7,410	30 New	30 $7,000

1,956

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.8B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Schubert & CO, based on Form 13F filings with the SEC.

Stay updated on Schubert & CO with notifications on news.